Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06766084

Enrollment

7878

Registered

2025-01-09

Start date

2009-01-01

Completion date

2023-12-31

Last updated

2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CABG, Revascularization

Brief summary

Retrospective study of adult patients with multivessel disease undergoing isolated coronary artery bypass grafting (CABG) in three centers between January 1st, 2009, and December 31st, 2023. Patients were grouped according to the revascularization strategy (total arterial revascularization vs. multiarterial grafting). Primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE).

Interventions

PROCEDURECABG

All patients underwent isolated CABG and retrospectively followed to asses clinical outcomes of the two different revascularization techniques

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* isolated CABG

Exclusion criteria

* single vessel CABG * CABG with utilization of only one arterial graft

Design outcomes

Primary

Measure	Time frame
MACCE	through study completion, a median of 101 months

Secondary

Measure	Time frame
Mortality	through study completion, a median of 101 months
MI	through study completion, a median of 101 months
CVA	through study completion, a median of 101 months
repeat revascularization	through study completion, a median of 101 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026